ZNF599 Inhibitors
Chemical inhibitors of ZNF599 can function through a variety of mechanisms, targeting different pathways that regulate the protein's activity. Compounds such as PD 98059 and U0126 are inhibitors of MEK, which is upstream of ERK in the MAPK pathway. Since ERK-mediated phosphorylation can regulate various proteins, the inhibition of MEK by these compounds would prevent such phosphorylation events, leading to the inhibition of ZNF599's function. Similarly, LY294002 and Wortmannin inhibit PI3K, which is part of the PI3K/AKT pathway, a crucial signaling route for many cellular functions. By inhibiting PI3K, these chemicals hinder the phosphorylation and activation of AKT, which in turn could regulate ZNF599, leading to its functional inhibition.
Additionally, SP600125, which targets JNK, and SB203580, which inhibits p38 MAP kinase, can disrupt the phosphorylation state of proteins within their respective pathways, potentially including those involved in the regulation of ZNF599. Rapamycin targets mTOR to disrupt protein synthesis necessary for ZNF599 function, while Staurosporine broadly targets kinases that may phosphorylate ZNF599 or its associated proteins. Y-27632's inhibition of ROCK can affect the actin cytoskeleton, possibly influencing the localization of ZNF599 and thus inhibiting it. MG-132 blocks the proteasome pathway, leading to the buildup of proteins that negatively regulate ZNF599, while Trichostatin A changes the chromatin structure, potentially impeding ZNF599's ability to bind DNA. Lastly, Alsterpaullone inhibits cyclin-dependent kinases, which may be necessary for ZNF599's phosphorylation and subsequent function, thereby resulting in its inhibition.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This compound inhibits MEK, which is upstream of ERK in the MAPK pathway. ZNF599 could be regulated by ERK-mediated phosphorylation, and inhibition of MEK by PD 98059 would prevent this phosphorylation, leading to the inhibition of ZNF599's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
As a PI3K inhibitor, LY294002 prevents the phosphorylation and activation of AKT. Since AKT can regulate a range of proteins through phosphorylation, inhibiting PI3K activity would impede any AKT-mediated regulation of ZNF599, thereby inhibiting its function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
This compound is a JNK inhibitor. By inhibiting JNK, SP600125 would prevent the JNK-mediated phosphorylation of proteins that may be involved in the functional regulation of ZNF599, thus inhibiting ZNF599. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAP kinase. If ZNF599 is regulated by p38 MAPK through phosphorylation or another regulatory mechanism, then inhibition of p38 MAPK by SB203580 would inhibit the function of ZNF599. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key regulator of cell growth and protein synthesis. By inhibiting mTOR, Rapamycin would disrupt the synthesis of proteins that are crucial for ZNF599 function, resulting in its inhibition. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor with a broad spectrum. By inhibiting various kinases that are possibly involved in the phosphorylation of ZNF599 or its co-regulatory proteins, Staurosporine would lead to the inhibition of ZNF599. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor. By inhibiting the PI3K/AKT pathway, Wortmannin would prevent the activation of downstream proteins that may regulate ZNF599, resulting in the functional inhibition of ZNF599. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are upstream of ERK in the MAPK pathway. Inhibition of MEK by U0126 would prevent the activation of ERK and its downstream effectors that could regulate ZNF599, thus inhibiting ZNF599. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 inhibits ROCK, which could affect the actin cytoskeleton and potentially influence the trafficking or localization of ZNF599, leading to its inhibition. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor that could lead to the accumulation of ubiquitinated proteins, which may include negative regulators of ZNF599. This accumulation could result in the inhibition of ZNF599 function. | ||||||